The purpose of this study is to investigate the safety and the prognosis after achieving reduced alcohol intake in patients with alcohol dependence who received treatment for the reduction of alcohol intake in the routine clinical setting in Japan.
Study Type
OBSERVATIONAL
Enrollment
533
Oral administration of nalmefene hydrochloride hydrate
Otsuka Pharmaceutical Co., Ltd.
Osaka, Japan
Alcohol Use Disorders Identification Test-Consumption(AUDIT-C)
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.